CatalystWireBeta

UK small-cap RNS · 6 Jul 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 18:00
    Trellus Health
    FTSE Russell removes Trellus from the FTSE AIM All-Share Index on 9 July 2026 after a 40-business-day suspension with no resumption date. This deepens the distress: shares stay frozen while funding and a possible sale of the US subsidiary remain unresolved.
    Balance-sheet stress / refinancing first in 7 months +0.0% on the day
    Moved: Cash runway and fundraising: Runway extended to 31 July; shares suspended → Shares suspended; removed from FTSE AIM All-Share
  2. 17:00
    Director/PDMR Shareholding Director dealing
  3. 16:47
    Director/PDMR Shareholding Director dealing
  4. 16:45
    Directorate Change Board change
    CEO departs by mutual agreement just two weeks after the FY2025 results, while the restructured company is trying to convert its pipeline into the FY2026 revenue target; no reason is given and no successor is named.
    Turnaround plan with targets first in 8 months −1.7% on the day
    Moved: Restructuring and turnaround: Audited FY2025 results; target and cost cuts confirmed → CEO exit; search for successor begins
  5. 14:30
    Director/PDMR Shareholding Director dealing
  6. 11:53
    Director/PDMR Shareholding Director dealing
  7. 11:40
    Director/PDMR Shareholding Director dealing
  8. 10:35
    Director/PDMR Shareholding Director dealing
  9. 09:38
    Bodycote BOY £1,541m
    Holding(s) in Company Holding
  10. 07:00
    Fiinu BANK £9.9m
    Response to Shareholder Letter
    Granicus, the Everfex seller (about 10.7% holder), has circulated a letter to shareholders before the 24 July AGM blaming management for the FY2025 loss. The Board rejects it and urges a vote for all resolutions.
    Turnaround plan with targets £16.0m · 162% of mcapfirst since Oct 2023 −4.8% on the day
    Moved: new: Granicus shareholder letter before AGM – Board rebutting seller's pre-AGM letter · Everfex SPA non-compete dispute: Legal and arbitration claims ongoing; no recovery booked → Arbitration plus warranty claims, over £16m · Everfex integration and governance overhaul: Integration ongoing; goodwill fully written off → Remediation implemented; goodwill already written off
  11. 07:00
    Operational Update
    J76 came online about two weeks late but at ~20,000 bopd, lifting Jubilee's exit rate above 85,000 bopd. Net debt fell to ~$2.56bn and the ~20% full-year reduction target is intact.
    Project milestones in lineoutlook positive +7.7% on the day
    Moved: Jubilee drilling campaign: J74 and J75 online; three more wells drilled → J76 online; J77 and J50 next · 2026 and 2027 debt maturities: EG sale proceeds to repay RBL → Net debt down; RBL refinancing talks due · Tiberius development: FID taken March 2026; farm-down under way → FID taken; farm-down progressing
  12. 07:00
    Commencement of share buy-back programme
    Starts the further buy-back of up to £50.0m for FY26, authorised in June, to cancel capital and support per-share earnings. It follows the CET1 uplift expected from the fleet sale; the company gives no guarantee of full execution.
    Capital return £50.0m · 4% of mcapfirst in 7 months +1.7% on the day
    Moved: FY26 share buy-back: £11.8m of £50.0m executed in December → Further £50.0m programme commenced via Peel Hunt
  13. 07:00
    Results for the year to 31 March 2026 Results
    This is a results release, not a guidance raise. It puts a figure on the EBITDA beat flagged in April: £2.6m against £2.3m consensus. Revenue of £31.6m is below the £32.0m given in April, unexplained.
    Project milestones £31.6m · 80% of mcapahead of expectationsoutlook positive +2.1% on the day
    Moved: New-build surgical hub: Under construction, on track and on budget → Under construction; opening early 2027/28

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note